MRWM Advisors, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1732949 NASHVILLE, TN

Position in BMY

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$856,521

-$73,000 QoQ

Shares Held

14,865

-3.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.45%

of 13F equity value

Holder Rank

#1,257

of 2,506 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MRWM Advisors, LLC holds $4,668,454 across 5 Drug Manufacturers - General names. BMY ranks #4 (18.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	5,570	$1,401,634
2	MRK	Merck & Co., Inc.	8,433	$1,083,640
3	AMGN	Amgen Inc	2,970	$1,075,496
4	BMY	Bristol Myers Squibb Co This page	14,865	$856,521
5	GILD	Gilead Sciences, Inc.	1,988	$251,163

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$856,521	14,865	-3.0%	Shares	Sole	2026-07-29
2026-03-31	$929,521	15,326	+122.8%	Shares	Sole	2026-04-21
2025-12-31	$371,107	6,880	-59.5%	Shares	Sole	2026-01-26
2025-09-30	$766,519	16,996	-5.0%	Shares	Sole	2025-10-28
2025-06-30	$827,757	17,882	+0.2%	Shares	Sole	2025-08-27
2025-03-31	$1,088,366	17,845	-0.1%	Shares	Sole	2025-08-27
2024-12-31	$1,010,557	17,867	—	Shares	Sole	2025-08-27
No filing history on record for this holder in this stock.